Cargando…
Effectivity of mesenchymal stem cells for bleomycin-induced pulmonary fibrosis: a systematic review and implication for clinical application
Pulmonary fibrosis (PF) is a chronic, progressive, fibrotic interstitial disease of the lung with poor prognosis and without effective treatment currently. Data from previous coronavirus infections, such as the Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome, as well as...
Autores principales: | Zhao, Yunyu, Yan, Zhipeng, Liu, Ying, Zhang, Yue, Shi, Jie, Li, Jingtao, Ji, Fanpu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380478/ https://www.ncbi.nlm.nih.gov/pubmed/34420515 http://dx.doi.org/10.1186/s13287-021-02551-y |
Ejemplares similares
-
Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis
por: Lan, Ying-Wei, et al.
Publicado: (2015) -
Adipose-derived mesenchymal stem cell therapy for reverse bleomycin-induced experimental pulmonary fibrosis
por: Zhao, Xiansheng, et al.
Publicado: (2023) -
Megakaryocytes participate in the occurrence of bleomycin-induced pulmonary fibrosis
por: Zhou, Yan, et al.
Publicado: (2019) -
Immune Mechanisms of Pulmonary Fibrosis with Bleomycin
por: Ishida, Yuko, et al.
Publicado: (2023) -
Distal airway stem cells ameliorate bleomycin-induced pulmonary fibrosis in mice
por: Shi, Yun, et al.
Publicado: (2019)